- Home
- ABEO vs ELMD Comparison
ABEO vs ELMD Comparison
Compare ABEO & ELMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ABEO | ELMD |
|---|---|---|
| Founded | 1974 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 399.5M | 326.9M |
| IPO Year | 2005 | 2010 |
Fundamental Metrics
Financial Performance| Metric | ABEO | ELMD |
|---|---|---|
| Price | $5.05 | $28.36 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 2 |
| Target Price | $18.88 | ★ $48.50 |
| AVG Volume (30 Days) | ★ 1.3M | 79.5K |
| Earning Date | 11-11-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 165.16 | 52.94 |
| EPS | N/A | ★ 1.30 |
| Revenue | $2,998,000.00 | ★ $54,716,000.00 |
| Revenue This Year | $804.33 | $12.71 |
| Revenue Next Year | $119.68 | $10.70 |
| P/E Ratio | ★ N/A | $21.76 |
| Revenue Growth | ★ 258.18 | 13.83 |
| 52 Week Low | $4.00 | $23.01 |
| 52 Week High | $7.65 | $47.40 |
Technical Indicators
Market Signals| Indicator | ABEO | ELMD |
|---|---|---|
| Relative Strength Index (RSI) | 35.55 | 37.76 |
| Support Level | $4.94 | $27.14 |
| Resistance Level | $5.46 | $28.35 |
| Average True Range (ATR) | 0.21 | 0.84 |
| MACD | -0.01 | 0.65 |
| Stochastic Oscillator | 11.39 | 86.79 |
Price Performance
Historical ComparisonAbout ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.
About ELMD Electromed Inc.
Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.